Johnson & Johnson proposes $6.5 Billion in settlement of talc cancer lawsuits

01 May 2024 - 2 minute read

Published in The Guardian, Reuters, BBC News

Home > News > Article

Johnson & Johnson has made a significant move to resolve ongoing litigation concerning its talc-based baby powder, proposing a substantial $6.5 billion settlement. This initiative aims to address thousands of lawsuits claiming the product is linked to cancer.

Here is a roundup of key stories covering this settlement:

Guardian News PaperThe Guardian The Guardian reports that Johnson & Johnson has agreed to a $6.5 billion settlement to resolve thousands of lawsuits alleging its talc-based baby powder caused cancer. While the company denies these claims, it will pay the settlement over 25 years to address current and future lawsuits. This decision, which follows extensive litigation, is part of a strategy to manage legal risks. The settlement still requires bankruptcy court approval.

Read the full Guardian article here.

If you or a loved one has been affected and believe you are eligible, register today.

 

Reuters ArticleReuters According to Reuters, Johnson & Johnson is advancing a $6.48 billion settlement to resolve tens of thousands of lawsuits alleging its talc products cause ovarian cancer. The settlement, which requires approval from 75% of claimants, involves a third bankruptcy filing for a subsidiary. J&J maintains that its talc products are safe and aims to settle 99% of related lawsuits. The company has set aside $11 billion for talc settlements and plans to address up to 100,000 claims through this deal. Critics argue that J&J's strategy favours certain claimants, but the company remains confident in securing necessary support.

Read the full Reuters article here.

BBC NewsBBC News Natalie Sherman of BBC News highlights that Johnson & Johnson has faced significant legal challenges, including a $2 billion judgment awarded to 22 women. Previous attempts to resolve the lawsuits through bankruptcy court were blocked, as judges ruled that the subsidiary created to handle the claims was not in financial distress. Despite ongoing legal disputes and some notable losses, J&J continues to assert that its talc products did not contain asbestos and did not cause cancer.

Read the full BBC article here.

Mail OnlineThe Daily Mail highlights the personal stories of victims who have taken legal action against Johnson & Johnson, claiming its talcum powder caused their cancers. These victims share their experiences of emotional and financial strain. The article emphasises the mounting evidence linking talcum powder to cancer and the severe impact on affected families. This landmark lawsuit seeks justice and compensation, underscoring the public health implications and the legal battles Johnson & Johnson faces in the UK.

Read the full Daily Mail article here.

This settlement aims to provide relief to thousands of claimants who have been waiting for compensation for years.
Erik Haas
Vice president of litigation | 01/05/2024

 

01 May 2024